肝门部胆管癌的进展与争议

李相成; 冯勤超

doi:10.3969/j.issn.1001-5256.2019.12.004

肝门部胆管癌的进展与争议

DOI: 10.3969/j.issn.1001-5256.2019.12.004

南京医科大学第一附属医院肝胆中心

基金项目:

江苏省重点病种规范化诊疗研究(BE2016789)；国家自然科学基金(81670570)；国家传染病重大专项(2017ZX10203207-004-004)；

详细信息

中图分类号: R735.8
计量
- 文章访问数: 1132
- HTML全文浏览量: 14
- PDF下载量: 362
- 被引次数: 0
出版历程
- 收稿日期: 2019-11-21
- 出版日期: 2019-12-20

Advance and controversy of hilar cholangiocarcinoma

Departmment of Hepatobiliary Surgery,First Affiliated Hospital of Nanjing Medical University

Research funding:

摘要

摘要: 肝门部胆管癌是胆道系统中最难治疗的恶性肿瘤之一,由于解剖位置特殊,常由于发现较晚而侵犯血管及肝实质,从而丧失最佳的治疗机会。虽然近年来随着诊断以及外科技术不断发展,对于肝门部胆管癌的疗效有所改善,但在肝门部胆管癌的准确定义、术前诊断与评估、手术方式和范围的选择、围手术期管理以及肝移植对肝门部胆管癌的应用等方面还存在许多争议,旨在对肝门部胆管癌诊治的进展与争议方面进行阐述。
- 胆管肿瘤 /
- 诊断 /
- 危险性评估 /
- 外科手术 /
- 围手术期 /
- 肝移植
Abstract: Hilar cholangiocarcinoma is one of the most difficult malignant tumors in the biliary system. The best chance of treatment often absent on account of the portal vein and liver lobe are invaded. Although the efficacy of hilar cholangiocarcinoma improved with the development of diagnosis and surgical techniques in recent years,accurate definition,preoperative diagnosis and assessment,operation approach and scope,perioperative management,and the application of liver transplantation still have many disputes. This article aims to reports the advance and controversy in diagnosis and treatment of Hilar cholangiocarcinoma.
- bile duct neoplasms /
- diagnosis /
- risk assessment /
- surgical procedures,operative /
- perioperative period /
- liver transplantation

HTML全文

参考文献(61)

[1] CAPOBIANCO I,ROLINGER J,NADALIN S. Resection for Klatskin tumors:Technical complexities and results[J].Transl Gastroenterol Hepatol,2018,3:69.

[2] BLECHACZ B. Cholangiocarcinoma:Current knowledge and new developments[J]. Gut Liver,2017,11(1):13-26.

[3] NAGINO M,EBATA T,YOKOYAMA Y,et al. Evolution of surgical treatment for perihilar cholangiocarcinoma:A singlecenter 34-year review of 574 consecutive resections[J]. Ann Surg,2013,258(1):129-140.

[4] KLATSKIN G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features[J]. Am J Med,1965,38:241-256.

[5] CAI XJ. Interpretation of the 8th edition of AJCC Cancer Staging Manual"hilar cholangiocarcinoma"[J]. J Clin Surg,2018,26(1):10-12.(in Chinese)蔡秀军．美国癌症联合会(AJCC)癌症分期手册第8版“肝门部胆管癌”部分更新解读[J]．临床外科杂志，2018,26(1):10-12.

[6] MB A. AJCC cancer staging manual[M]. New York:Springer,2016.

[7] Study Group of Biliary Tract Surgery in Chinese Society of Surgery of Chinese Medical Association,Hepatobiliary Surgery Professional Committee of PLA. Guidelines for diagnosis and treatment of hilar cholangiocarcinoma(2013)[J]. Chin J Surg,2013,51(10):865-871.(in Chinese)中华医学会外科学分会胆道外科学组，解放军全军肝胆外科专业委员会．肝门部胆管癌诊断和治疗指南(2013版)[J]．中华外科杂志，2013,51(10):865-871.

[8] EBATA T,KOSUGE T,HIRANO S,et al. Proposal to modify the International Union Against Cancer staging system for perihilar cholangiocarcinomas[J]. Br J Surg,2014,101(2):79-88.

[9] LI XC,JIANG WJ. Advance in diagnosis and treatment of hilar cholangiocarcinoma[J]. J Abdominal Surg,2019,32(1):7-12.(in Chinese)李相成，江王杰．肝门部胆管癌诊治进展[J]．腹部外科，2019,32(1):7-12.

[10] BISMUTH H,CORLETTE MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver[J]. Surg Gynecol Obstet,1975,140(2):170-178.

[11] GASPERSZ MP,BUETTNER S,van VUGT J,et al. Evaluation of the New American Joint Committee on cancer staging manual 8th edition for perihilar cholangiocarcinoma[J]. J Gastrointest Surg,2019.[Epub ahead of print]

[12] SUAREZ-MUNOZ MA,FERNANDEZ-AGUILAR JL,SANCHEZ-PEREZ B,et al. Risk factors and classifications of hilar cholangiocarcinoma[J]. World J Gastrointest Oncol,2013,5(7):132-138.

[13] DEOLIVEIRA ML,SCHULICK RD,NIMURA Y,et al. New staging system and a registry for perihilar cholangiocarcinoma[J]. Hepatology,2011,53(4):1363-1371.

[14] VARGHESE JC,FARRELL MA,COURTNEY G,et al. A prospective comparison of magnetic resonance cholangiopancreatography with endoscopic retrograde cholangiopancreatography in the evaluation of patients with suspected biliary tract disease[J]. Clin Radiol,1999,54(8):513-520.

[15] FARRELL RJ,AGARWAL B,BRANDWEIN SL,et al. Intraductal US is a useful adjunct to ERCP for distinguishing malignant from benign biliary strictures[J]. Gastrointest Endosc,2002,56(5):681-687.

[16] JOO I,LEE JM,YOON JH. Imaging diagnosis of intrahepatic and perihilar cholangiocarcinoma:Recent advances and challenges[J]. Radiology,2018,288(1):7-13.

[17] OLIVEIRA IS,KILCOYNE A,EVERETT JM,et al. Cholangiocarcinoma:Classification,diagnosis,staging,imaging features,and management[J]. Abdom Radiol(NY),2017,42(6):1637-1649.

[18] CHEN HW,PAN AZ,ZHEN ZJ,et al. Preoperative evaluation of resectability of Klatskin tumor with 16-MDCT angiography and cholangiography[J]. AJR Am J Roentgenol,2006,186(6):1580-1586.

[19] LEE HY,KIM SH,LEE JM,et al. Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma:Combined CT and cholangiography with revised criteria[J]. Radiology,2006,239(1):113-121.

[20] ALOIA TA,CHARNSANGAVEJ C,FARIA S,et al. High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma[J]. Am J Surg,2007,193(6):702-706.

[21] TILLICH M,MISCHINGER HJ,PREISEGGER KH,et al. Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma[J]. AJR Am J Roentgenol,1998,171(3):651-658.

[22] RAZUMILAVA N,GORES GJ. Cholangiocarcinoma[J]. Lancet,2014,383(9935):2168-2179.

[23] PARK MJ,KIM YK,LIM S,et al. Hilar cholangiocarcinoma:Value of adding DW imaging to gadoxetic acid-enhanced MR imaging with MR cholangiopancreatography for preoperative evaluation[J]. Radiology,2014,270(3):768-776.

[24] TOUMI N,ABID H,HENCHIR S,et al. Role of magnetic resonance imaging in preoperative assessement of hilar cholangiocarcinoma[J]. Presse Med,2018,47(11-12 Pt 1):950-960.

[25] SOARES KC,KAMEL I,COSGROVE DP,et al. Hilar cholangiocarcinoma:Diagnosis, treatment options, and management[J]. Hepatobiliary Surg Nutr,2014,3(1):18-34.

[26] ROMANEEHSEN B,OTTO G,LOHSE AW,et al. Diagnostic imaging of hilar cholangiocarcinoma:Preoperative evaluation of ERC,MRC and PTC in comparison with histopathology[J].Rofo,2004,176(12):1750-1758.

[27] WEBER A,von WEYHERN C,FEND F,et al. Endoscopic transpapillary brush cytology and forceps biopsy in patients with hilar cholangiocarcinoma[J]. World J Gastroenterol,2008,14(7):1097-1101.

[28] HIJIOKA S,HARA K,MIZUNO N,et al. A novel technique for endoscopic transpapillary"mapping biopsy specimens"of superficial intraductal spread of bile duct carcinoma(with videos)[J]. Gastrointest Endosc,2014,79(6):1020-1025.

[29] KAWASHIMA H,ITOH A,OHNO E,et al. Preoperative endoscopic nasobiliary drainage in 164 consecutive patients with suspected perihilar cholangiocarcinoma:A retrospective study of efficacy and risk factors related to complications[J]. Ann Surg,2013,257(1):121-127.

[30] SAKUMA Y,KODAMA Y,SOGABE Y,et al. Diagnostic performance of a new endoscopic scraper for malignant biliary strictures:A multicenter prospective study[J]. Gastrointest Endosc,2017,85(2):371-379.

[31] JI GW,ZHU FP,LI XC. Progress in application of three-dimensional imaging technique in complex hepatobiliary surgery[J]. Chin J Surg,2017,55(4):316-320.(in Chinese)季顾惟，朱飞鹏，李相成．三维影像学技术在复杂肝胆外科手术中的应用进展[J]．中华外科杂志，2017,55(4):316-320.

[32] WANG Y,YANG H,SHEN C,et al. Surgical procedure and long-term survival of hilar cholangiocarcinoma[J]. Int J Clin Exp Med,2015,8(1):1122-1128.

[33] LIM JH,CHOI GH,CHOI SH,et al. Liver resection for Bismuth type I and Type II hilar cholangiocarcinoma[J]. World J Surg,2013,37(4):829-837.

[34] XIONG J,NUNES QM,HUANG W,et al. Major hepatectomy in Bismuth types I and II hilar cholangiocarcinoma[J]. J Surg Res,2015,194(1):194-201.

[35] HIROSE T,IGAMI T,EBATA T,et al. Surgical and Radiological Studies on the Length of the Hepatic Ducts[J]. World J Surg,2015,39(12):2983-2989.

[36] KUANG D,WANG GP. Hilar cholangiocarcinoma:Pathology and tumor biology[J]. Front Med China,2010,4(4):371-377.

[37] JARNAGIN WR,BOWNE W,KLIMSTRA DS,et al. Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma[J]. Ann Surg,2005,241(5):703-712; discussion 712-714.

[38] de JONG MC,MARQUES H,CLARY BM,et al. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma:A multi-institutional analysis of 305 cases[J]. Cancer,2012,118(19):4737-4747.

[39] MATSUYAMA R,MORI R,OTA Y,et al. Significance of vascular resection and reconstruction in surgery for hilar cholangiocarcinoma:With special reference to hepatic arterial resection and reconstruction[J]. Ann Surg Oncol,2016,23(Suppl4):475-484.

[40] YOUNG AL,IGAMI T,SENDA Y,et al. Evolution of the surgical management of perihilar cholangiocarcinoma in a Western centre demonstrates improved survival with endoscopic biliary drainage and reduced use of blood transfusion[J]. HPB(Oxford),2011,13(7):483-493.

[41] NAGINO M,NIMURA Y,NISHIO H,et al. Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma:An audit of 50 consecutive cases[J]. Ann Surg,2010,252(1):115-123.

[42] CHEN W,KE K,CHEN YL. Combined portal vein resection in the treatment of hilar cholangiocarcinoma:A systematic review and meta-analysis[J]. Eur J Surg Oncol,2014,40(5):489-495.

[43] HARTOG H,IJZERMANS JN,van GULIK TM,et al. Resection of Perihilar Cholangiocarcinoma[J]. Surg Clin North Am,2016,96(2):247-267.

[44] MAO K,LIU J,SUN J,et al. Patterns and prognostic value of lymph node dissection for resected perihilar cholangiocarcinoma[J]. J Gastroenterol Hepatol,2016,31(2):417-426.

[45] GIULIANTE F,ARDITO F,GUGLIELMI A,et al. Association of lymph node status with survival in patients after Liver resection for hilar cholangiocarcinoma in an Italian multicenter analysis[J]. JAMA Surg,2016,151(10):916-922.

[46] KAMBAKAMBA P,LINECKER M,SLANKAMENAC K,et al.Lymph node dissection in resectable perihilar cholangiocarcinoma:A systematic review[J]. Am J Surg,2015,210(4):694-701.

[47] LI XC,JI GW. Radical resection of hilar cholangiocarcinoma[J]. J Surg Concepts Pract,2017,22(3):185-190.(in Chinese)李相成，季顾惟．肝门部胆管癌的根治性切除[J]．外科理论与实践，2017,22(3):185-190.

[48] BELGHITI J,HIRAMATSU K,BENOIST S,et al. Seven hundred forty-seven hepatectomies in the 1990s:An update to evaluate the actual risk of liver resection[J]. J Am Coll Surg,2000,191(1):38-46.

[49] KAWAKAMI H,KUWATANI M,ONODERA M,et al. Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma[J]. J Gastroenterol,2011,46(2):242-248.

[50] ZHANG XF,BEAL EW,MERATH K,et al. Oncologic effects of preoperative biliary drainage in resectable hilar cholangiocarcinoma:Percutaneous biliary drainage has no adverse effects on survival[J]. J Surg Oncol,2018,117(6):1267-1277.

[51] MAY BJ,MADOFF DC. Controversies of preoperative portal vein embolization[J]. Hepat Oncol,2016,3(2):155-166.

[52] PICHLMAYR R,WEIMANN A,TUSCH G,et al. Indications and role of liver transplantation for malignant tumors[J]. Oncologist,1997,2(3):164-170.

[53] MEYER CG,PENN I,JAMES L. Liver transplantation for cholangiocarcinoma:Results in 207 patients[J]. Transplantation,2000,69(8):1633-1637.

[54] ROBLES R,FIGUERAS J,TURRIN VS,et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma[J]. Ann Surg,2004,239(2):265-271.

[55] de VREEDE I,STEERS JL,BURCH PA,et al. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma[J]. Liver Transpl,2000,6(3):309-316.

[56] HEIMBACH JK,GORES GJ,HADDOCK MG,et al. Liver transplantation for unresectable perihilar cholangiocarcinoma[J]. Semin Liver Dis,2004,24(2):201-207.

[57] ROSEN CB,HEIMBACH JK,GORES GJ. Liver transplantation for cholangiocarcinoma[J]. Transpl Int,2010,23(7):692-697.

[58] GORES GJ,DARWISH MURAD S,HEIMBACH JK,et al. Liver transplantation for perihilar cholangiocarcinoma[J]. Dig Dis,2013,31(1):126-129.

[59] MACHAIRAS N,KOSTAKIS ID,TSILIMIGRAS DI,et al. Liver transplantation for hilar cholangiocarcinoma:A systematic review[J]. Transplant Rev(Orlando),2020,34(1):100516.

[60] DARWISH MURAD S,KIM WR,HARNOIS DM,et al. Efficacy of neoadjuvant chemoradiation,followed by liver transplantation,for perihilar cholangiocarcinoma at 12 US centers[J].Gastroenterology,2012,143(1):88-98. e3; quiz e14.

[61] MORIS D,KOSTAKIS ID,MACHAIRAS N,et al. Comparison between liver transplantation and resection for hilar cholangiocarcinoma:A systematic review and meta-analysis[J].PLo S One,2019,14(7):e0220527.

施引文献

资源附件(0)

访问统计